Veldona (interferon-alpha oral lozenges) - Hayashibara, Otsuka, Amarillo
Amarillo Biosciences: Annual Report 2014 (Amarillo) - Jul 9, 2015 - Anticipated expiry of patent for method of treatment of autoimmune disorders in December 2015; Anticipated expiry of patent for method of treatment of fibromyalgia in March 2018; Anticipated expiry of patent for interferon dosage form and method in April 2019; Anticipated expiry of patent for composition and method for promoting oral health in April 2021 
Anticipated patent expiry Fibrosis
http://www.sec.gov/Archives/edgar/data/1014763/000101476315000006/form10k_12312014.htm
 
Jul 9, 2015
 
.